Association of thrombotic microangiopathy with atezolizumab therapy in cancer patients

Hassan Izzedine; Alexis Mathian; Laurence Albiges; Stéphane Champiat; Isabelle Brocheriou

doi:10.1016/j.ejca.2021.02.033

Association of thrombotic microangiopathy with atezolizumab therapy in cancer patients

Hassan Izzedine, Alexis Mathian, Laurence Albiges, Stéphane Champiat, Isabelle Brocheriou

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

3 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	34-36
Nombre de pages	3
journal	European Journal of Cancer
Volume	149
Les DOIs	https://doi.org/10.1016/j.ejca.2021.02.033
état	Publié - 1 mai 2021

Accès au document

10.1016/j.ejca.2021.02.033

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{606fd8159cea432fa60615e0bc885f5c,

title = "Association of thrombotic microangiopathy with atezolizumab therapy in cancer patients",

keywords = "Acute kidney injury, Atezolizumab, Immune checkpoint inhibitor, Nephrotoxicity, Onconephrology, PD-L1, PD-L1 inhibitor, Programmed cell death ligand 1, Renal cell carcinoma, Thrombotic microangiopathy",

author = "Hassan Izzedine and Alexis Mathian and Laurence Albiges and St{\'e}phane Champiat and Isabelle Brocheriou",

year = "2021",

month = may,

day = "1",

doi = "10.1016/j.ejca.2021.02.033",

language = "English",

volume = "149",

pages = "34--36",

journal = "European Journal of Cancer",

issn = "0959-8049",

}

TY - JOUR

T1 - Association of thrombotic microangiopathy with atezolizumab therapy in cancer patients

AU - Izzedine, Hassan

AU - Mathian, Alexis

AU - Albiges, Laurence

AU - Champiat, Stéphane

AU - Brocheriou, Isabelle

PY - 2021/5/1

Y1 - 2021/5/1

KW - Acute kidney injury

KW - Atezolizumab

KW - Immune checkpoint inhibitor

KW - Nephrotoxicity

KW - Onconephrology

KW - PD-L1

KW - PD-L1 inhibitor

KW - Programmed cell death ligand 1

KW - Renal cell carcinoma

KW - Thrombotic microangiopathy

UR - http://www.scopus.com/inward/record.url?scp=85103582367&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2021.02.033

DO - 10.1016/j.ejca.2021.02.033

M3 - Letter

C2 - 33819719

AN - SCOPUS:85103582367

SN - 0959-8049

VL - 149

SP - 34

EP - 36

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -